Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jirak

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Plos One|February 26, 2021
Impella use in real-world cardiogenic shock patients: Sobering outcomesKhaled Q A Abdullah, Jana V Roedler, Juergen Vom Dahl, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 14, 2018
Hypoglycemia but Not Hyperglycemia Is Associated with Mortality in Critically Ill Patients with DiabetesBernhard Wernly, Peter Jirak, Michael Lichtenauer, et al.
European Journal of Internal Medicine|June 6, 2017
A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failureMichael Lichtenauer, Peter Jirak, Bernhard Wernly, et al.
Journal of Clinical Medicine|April 25, 2020
Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and ControlsPeter Jirak, Rudin Pistulli, Michael Lichtenauer, et al.
Journal of Clinical Medicine|February 23, 2020
Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial InfarctionNaufal Zagidullin, Lukas J Motloch, Diana Gareeva, et al.
Frontiers in Medicine|February 21, 2022
Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter AnalysisPeter Jirak, Vincent van Almsick, Dimitrios Dimitroulis, et al.
Frontiers in Cardiovascular Medicine|May 4, 2023
Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly-results of a retrospective multi-center studyElke Boxhammer, Meriem Bellamine, Istvan Szendey, et al.
Journal of Clinical Medicine|July 16, 2020
Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial InfarctionSebastian J Reinstadler, Martin Reindl, Ivan Lechner, et al.
Journal of Clinical Medicine|May 13, 2023
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and FructosamineBernhard Ohnewein, Zornitsa Shomanova, Vera Paar, et al.
Frontiers in Cardiovascular Medicine|December 13, 2021
Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe PneumoniaPeter Jirak, Zornitsa Shomanova, Robert Larbig, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Plos One|February 26, 2021
Impella use in real-world cardiogenic shock patients: Sobering outcomesKhaled Q A Abdullah, Jana V Roedler, Juergen Vom Dahl, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 14, 2018
Hypoglycemia but Not Hyperglycemia Is Associated with Mortality in Critically Ill Patients with DiabetesBernhard Wernly, Peter Jirak, Michael Lichtenauer, et al.
European Journal of Internal Medicine|June 6, 2017
A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failureMichael Lichtenauer, Peter Jirak, Bernhard Wernly, et al.
Journal of Clinical Medicine|April 25, 2020
Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and ControlsPeter Jirak, Rudin Pistulli, Michael Lichtenauer, et al.
Journal of Clinical Medicine|February 23, 2020
Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial InfarctionNaufal Zagidullin, Lukas J Motloch, Diana Gareeva, et al.
Frontiers in Medicine|February 21, 2022
Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter AnalysisPeter Jirak, Vincent van Almsick, Dimitrios Dimitroulis, et al.
Frontiers in Cardiovascular Medicine|May 4, 2023
Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly-results of a retrospective multi-center studyElke Boxhammer, Meriem Bellamine, Istvan Szendey, et al.
Journal of Clinical Medicine|July 16, 2020
Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial InfarctionSebastian J Reinstadler, Martin Reindl, Ivan Lechner, et al.
Journal of Clinical Medicine|May 13, 2023
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and FructosamineBernhard Ohnewein, Zornitsa Shomanova, Vera Paar, et al.
Frontiers in Cardiovascular Medicine|December 13, 2021
Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe PneumoniaPeter Jirak, Zornitsa Shomanova, Robert Larbig, et al.
Pageof 6